H. S. Blanchette et al. / Tetrahedron 56 (2000) 9581±9588
9585
TLC, 3:1 cyclohexane/benzene) afforded 10 as a light
orange oil (1.04 g, 52%). H NMR (CD2Cl2) d 7.47±7.42
graphy (hexanes) gave 5 as a white crystalline solid
1
1
(179 mg, 72%). Mp1408C (dec); H NMR d 7.43 (dd,
(m, 4H), 7.28±7.23 (m, 4H), 2.84 (s, 4H), 0.29 (s, 18H); 13C
NMR (CD2Cl2) d 132.60, 132.52, 128.83, 128.17, 126.87,
126.00, 104.09, 98.75, 93.25, 80.60, 20.60, 0.32; IR (neat)
n3069, 2156 cm21; MS (EI, 70 eV) 422 (5, M1), 407 (10,
M12Me), 349 (49, M12SiMe3), 333 (54), 319 (38), 73
(100, SiMe3); HRMS calcd for C28H30Si2: 422.1886,
found: 422.1868.
J7.5, 1.2 Hz, 2H), 7.36 (dd, J7.5, 1.2 Hz, 2H), 7.32±
7.20 (m, 4H), 2.86 (s, 4H); 13C NMR (CD2Cl2) d 132.45,
130.49, 130.06, 129.61, 128.25, 124.83, 94.37, 85.45, 79.83,
79.67, 19.78; IR (KBr) n3057, 2208 cm21; UV (CH2Cl2)
lmax (e) 252 (21,600), 266 (24,300), 313 (7,000), 324
(7,100), 335 (12,300), 360 (15,600) nm; MS (EI, 70 eV)
276 (100, M1), 274 (82), 248 (14); HRMS calcd for
C22H12: 276.0939, found: 276.0940.
1,8-Bis(20-(trimethylsilylethynyl)phenyl)-1,7-octadiyne
(11). Compound 11 was prepared in an analogous fashion to
10. Thus, use of 1,7-octadiyne (0.637 g, 6.0 mmol) in the
above procedure furnished the corresponding bis(bromo-
phenyl)diyne as a colorless, crystalline solid (1.93 g,
1,2,7,8-Dibenzocyclohexadeca-3,5,9,15-tetrayne
(6).
Tetrayne 11 was deprotected in an analogous fashion to
10. The resultant brown oil was used immediately in the
1
next step. H NMR d 7.47 (d, J7.7 Hz, 2H), 7.40 (d,
1
77%). Rf0.31 (5:1 hexanes/CH2Cl2); H NMR (CD2Cl2)
J7.6 Hz, 2H), 7.29±7.18 (m, 4H), 3.32 (s, 2H), 2.55 (br
d 7.57 (dd, J8.1, 1.3 Hz, 2H), 7.44 (dd, J7.5, 1.7 Hz,
2H), 7.25 (td, J7.7, 1.3 Hz, 2H), 7.14 (td, J7.8, 1.7 Hz,
2H), 2.59±2.52 (m, 4H), 1.89±1.84 (m, 4H); 13C NMR d
133.18, 132.15, 128.59, 126.77, 125.89, 125.41, 94.86,
79.74, 27.45, 19.03; IR (KBr) n3061, 2233 cm21; UV-
Vis (CH2Cl2) lmax (e) 247 (26,400), 258 (26,900), 283
(760) nm; HRMS calcd for C20H16Br2: 413.9619, found:
413.9626.
s, 4H), 1.88 (br s, 4H).
In a manner analogous to 10, desilylated 11 was intra-
molecularly cross-coupled. Puri®cation of the crude yellow
solid obtained ®rst by preparative TLC (2:1 cyclohexane/
CH2Cl2, Rf0.35), then by radial chromatography (hexanes)
furnished 6 as a white crystalline solid (120 mg, 87%).
Mp141.7±142.58C; 1H NMR (CD2Cl2) d 7.51 (dd,
J7.4, 1.4 Hz, 2H), 7.40 (dd, J7.7, 1.4 Hz, 2H), 7.34±
7.23 (m, 4H), 2.57±2.49 (m, 4H), 1.92±1.85 (m, 4H); 13C
NMR (CD2Cl2) d 132.64, 131.76, 129.54, 128.70, 127.95,
125.03, 96.09, 81.94, 79.89, 77.82, 29.02, 20.30; IR (KBr)
n3061, 2226, 2144 cm21; UV (CH2Cl2) lmax (e) 249
(12,100), 264 (12,800), 309 (7,800), 330 (12,000), 353
(14,700) nm; MS (EI, 70 eV) 304 (100, M1), 303 (52),
302 (84), 300 (26), 289 (22), 276 (30); HRMS calcd for
C24H16: 304.1252, found: 304.1248.
Bis(bromophenyl)octadiyne (2.04 g, 5.0 mmol) was treated
as above. Chromatography over silica gel (hexanes/CH2Cl2,
20 to 35% CH2Cl2) gave 11 as an orange oil (1.19 g, 53%).
Rf0.44 (4:1 hexanes/CH2Cl2); 1H NMR (CD2Cl2) d 7.45±
7.38 (m, 2H), 7.28±7.19 (m, 4H), 2.55 (br t, J6.3 Hz, 4H),
1.85 (m, 4H), 0.26 (s, 18H); 13C NMR (CD2Cl2) d 132.60,
132.39, 128.75, 127.83, 127.22, 125.87, 104.20, 98.47,
94.88, 79.89, 28.55, 19.64, 0.24; IR (neat) n3062, 3024,
2231, 2159 cm21; UV±Vis (CH2Cl2) lmax (e) 240 (35,300),
265 (24,000), 279 (22,300), 297 (2,100), 309 (1,600) nm;
MS (EI, 70 eV) 450 (69, M1), 449 (70), 435 (17, M12Me),
422 (22), 407 (58), 73 (100, SiMe3); HRMS calcd for
C30H34Si2: 450.2199, found: 450.2207.
cis-1,6-Bis(20-(triisopropylsilylethynyl)phenyl)hex-3-en-
1,5-diyne (13). To a solution of diyne 1212 (2.13 g,
6.0 mmol) in MeOH (75 mL) and Et2O (15 mL) was
added anhydrous K2CO3 (415 mg, 3.0 mmol). After
stirring for 2 h, the mixture was diluted with Et2O,
washed with water, dried (MgSO4), and concentrated.
The resultant yellow oil was used immediately in the next
1,2,7,8-Dibenzocyclotetradeca-3,5,9,13-tetrayne (5). To a
solution of 10 (0.405 g, 0.96 mmol) in a mixture of MeOH
(15 mL) and Et2O (5 mL) was added K2CO3 (0.144 g,
1.04 mmol). After stirring for 3 h, the reaction mixture
was poured into Et2O (30 mL) and then washed with H2O
and brine. The organic layer was dried (MgSO4) and
concentrated to produce a brown oil which was immediately
1
step. H NMR d 7.51±7.47 (m, 4H), 7.29±7.24 (m, 4H),
3.26 (s, 1H), 1.15 (s, 21H); 13C NMR d 132.52, 132.42,
128.30, 127.89, 126.68, 124.94, 104.79, 95.28, 82.26,
81.03.
1
used in the next step. H NMR d 7.47 (d, J7.5 Hz, 2H),
To a degassed mixture of cis-1,2-dichloroethene (0.237 g,
2.5 mmol), CuI (0.024 g, 0.13 mmol), Pd(PPh3)4 (0.046 g,
0.04 mmol) and BuNH2 (2.0 mL) in dry THF (10 mL) was
added deprotected 12. After stirring for 18 h, the resultant
dark reaction mixture was poured into hexanes and washed
with 1 M HCl solution. The organic phase was dried
(MgSO4), concentrated, and chromatographed on silica gel
(hexanes) to give 13 as a pale yellow oil (0.619 g, 42%). 1H
NMR d 7.55±7.48 (m, 4H), 7.28±7.24 (m, 4H), 6.11 (s,
2H), 1.16 (s, 42H); 13C NMR d 1132.40, 132.20, 128.06,
127.92, 125.98, 125.85, 119.68, 105.08, 96.44, 96.44, 90.95,
18.77, 11.30; IR (neat) n3061, 2156 cm21; MS (EI,
70 eV) 588 (8, M1), 545 (11, M12i-Pr), 503 (30), 461
(30), 274 (100, M122Sii-Pr3); HRMS calcd for
C40H52Si2: 588.3608, found: 588.3615.
7.41 (d, J7.6 Hz, 2H), 7.28±7.18 (m, 4H), 3.26 (s, 2H),
2.83 (s, 4H).
To a solution of deprotected 10 in pyridine (80 mL) at 408C
was added CuCl (0.101 g, 1.02 mmol), DBU (165 mL,
1.10 mmol), and additional pyridine (10 mL) to complete
the transfer. O2 was bubbled through the mixture for
90 min while maintaining the temperature of the reaction
at 40±458C. After an additional 30 min of warming, the
mixture was concentrated (ca. 90%) in vacuo. To the slurry
was added a solution of KCN (54 mg, 0.82 mmol) and
NH4Cl (210 mg, 3.91 mmol) in water (2 mL) and the
mixture was stirred vigorously for 30 min. The ether
phase was washed with 2 M HCl solution, dried (MgSO4),
and concentrated. Puri®cation by preparative TLC (2:1
cyclohexane/CH2Cl2, Rf0.41), then by radial chromato-
1,2,7,8-Dibenzocyclotetradeca-11-en-3,5,9,13-tetrayne